MIRM — Mirum Pharmaceuticals, Inc. stock price, charts and financials

QT49Mirum Pharmaceuticals, Inc.

Mirum Pharmaceuticals, Inc. (NASDAQ: MIRM) is a Healthcare company in the Biotechnology industry. QuoTrend tracks its price, financials, earnings, analyst ratings and insider trades.

Latest market price
91.83
-6.99-7.07%
MIRMQT49Mirum Pharmaceuticals, Inc.·NASDAQ
91.83-7.07%

Latest SEC Filings

Form category
Filing DateFormDescriptionFilingDocument
Sep 15, 20264Statement of changes in beneficial ownership
Sep 08, 20268-KCurrent report
Sep 03, 20264Statement of changes in beneficial ownership
Sep 03, 20264Statement of changes in beneficial ownership
Aug 19, 20264Statement of changes in beneficial ownership
Aug 13, 2026SC 13G/ABeneficial ownership statement (passive, amended)
Aug 12, 20264Statement of changes in beneficial ownership
Aug 11, 20264Statement of changes in beneficial ownership
Aug 06, 2026SC 13GBeneficial ownership statement (passive)
Aug 05, 20264Statement of changes in beneficial ownership
Aug 05, 202610-QQuarterly report
Aug 05, 20268-KCurrent report
Jul 08, 20264Statement of changes in beneficial ownership
Jul 08, 20264Statement of changes in beneficial ownership
Jul 02, 20264Statement of changes in beneficial ownership
Jun 18, 20268-KCurrent report
Jun 18, 20264Statement of changes in beneficial ownership
Jun 17, 20264Statement of changes in beneficial ownership
Jun 17, 20264Statement of changes in beneficial ownership
Jun 17, 20264Statement of changes in beneficial ownership
Jun 17, 20264Statement of changes in beneficial ownership
Jun 17, 20264Statement of changes in beneficial ownership
Jun 17, 20264Statement of changes in beneficial ownership
Jun 17, 20264Statement of changes in beneficial ownership
Jun 17, 20264Statement of changes in beneficial ownership